Gilead Sciences
GILD
#107
Rank
S$231.20 B
Marketcap
S$186.46
Share price
-0.92%
Change (1 day)
23.25%
Change (1 year)

Gilead Sciences (GILD) - Total assets

Total assets on the balance sheet as of June 2026 : S$63.25 Billion

According to Gilead Sciences's latest financial reports the company's total assets are S$63.25 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Gilead Sciences - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-12-31S$75.77 B-5.5%
2024-12-31S$80.19 B-2.26%
2023-12-31S$82.04 B-3.12%
2022-12-31S$84.68 B-7.81%
2021-12-31S$91.86 B1.51%
2020-12-31S$90.49 B8.92%
2019-12-31S$83.08 B-4.49%
2018-12-31S$86.98 B-7.46%
2017-12-31S$94.00 B14%
2016-12-31S$82.46 B12.73%
2015-12-31S$73.15 B59.71%
2014-12-31S$45.80 B60.11%
2013-12-31S$28.60 B10.14%
2012-12-31S$25.97 B15.91%
2011-12-31S$22.40 B50.06%
2010-12-31S$14.93 B9.67%
2009-12-31S$13.61 B37.25%
2008-12-31S$9.92 B18.15%
2007-12-31S$8.39 B34.01%
2006-12-31S$6.26 B-0.09%
2005-12-31S$6.27 B78.29%
2004-12-31S$3.51 B33.15%
2003-12-31S$2.64 B18.18%
2002-12-31S$2.23 B51.92%
2001-12-31S$1.47 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
S$257.66 B 307.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$257.75 B 307.46%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$173.15 B 173.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$182.33 B 188.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$122.56 B 93.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$41.11 B-35.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$8.40 B-86.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$35.14 B-44.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$166.34 B 162.96%๐Ÿ‡บ๐Ÿ‡ธ USA